Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 130,000 | reported | 15 May 2025 | tx 5+445,000 |
| RAPT Therapeutics, Inc. | 36,490 | reported | 23 May 2024 | tx 16+192,757−360,344 |
| XENOPORT INC | 0 | reported | 05 Jul 2016 | tx 71+790,817−593,892 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 15+370,075−3,419,415 |
| Anacor Pharmaceuticals Inc | 0 | reported | 24 Jun 2016 | tx 20+183,256−183,256 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 130,000 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Lyell Immunopharma, Inc. | 130,000 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | RAPT Therapeutics, Inc. | 36,490 | 0.00 USD | deriv |
| 05 Apr 2024 | TENDER | NGM BIOPHARMACEUTICALS INC | 2,769,168 | — | |
| 05 Apr 2024 | TENDER | NGM BIOPHARMACEUTICALS INC | 5,172 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 75,000 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 80,000 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 50,000 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 225,000 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 78,407 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 80,000 | — | deriv |
| 28 Mar 2024 | GRANT_AWARD | RAPT Therapeutics, Inc. | 11,871 | 7.58 USD | deriv |
| 08 Sept 2023 | GRANT_AWARD | Lyell Immunopharma, Inc. | 55,000 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Lyell Immunopharma, Inc. | 65,000 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | RAPT Therapeutics, Inc. | 12,940 | 0.00 USD | deriv |
| 10 May 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 78,407 | 0.00 USD | deriv |
| 31 Mar 2023 | GRANT_AWARD | RAPT Therapeutics, Inc. | 6,026 | 14.52 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Lyell Immunopharma, Inc. | 65,000 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | RAPT Therapeutics, Inc. | 8,500 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | RAPT Therapeutics, Inc. | 5,207 | 16.80 USD | deriv |
| 03 Mar 2022 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 80,000 | 0.00 USD | deriv |
| 28 May 2021 | GRANT_AWARD | RAPT Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 17 Mar 2021 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 80,000 | 0.00 USD | deriv |
| 19 Nov 2020 | PURCHASE | RAPT Therapeutics, Inc. | 10,000 | 16.22 USD | first after silence |
| 18 Jun 2020 | GRANT_AWARD | RAPT Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 19 Nov 2020.